We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JHG
851
DELISTED
Janus Henderson
JHG
– –
-5,384
Closed -$240K
JOBY icon
852
Joby Aviation
JOBY
$7.12B
– –
-19,856
Closed -$320K
JOE icon
853
St. Joe Company
JOE
$3.6B
– –
-4,742
Closed -$235K
JRVR icon
854
James River Group Holdings
JRVR
$222M
– –
-10,620
Closed -$58.9K
OPLN
855
Openlane
OPLN
$4.27B
– –
-10,209
Closed -$294K
KNSA icon
856
Kiniksa Pharmaceuticals
KNSA
$6.06B
– –
-6,722
Closed -$261K
KNSL icon
857
Kinsale Capital Group
KNSL
$8.43B
– –
-474
Closed -$202K
KRNY icon
858
Kearny Financial
KRNY
$608M
– –
-18,656
Closed -$123K
KRT icon
859
Karat Packaging
KRT
$827M
– –
-15,618
Closed -$394K
KVYO icon
860
Klaviyo
KVYO
$5.66B
– –
-9,516
Closed -$263K
LAC
861
Lithium Americas
LAC
$986M
– –
-29,569
Closed -$169K
MZTI
862
The Marzetti Company
MZTI
$3.04B
– –
-2,111
Closed -$365K
LBTYA icon
863
Liberty Global Class A
LBTYA
$3.49B
– –
-15,090
Closed -$173K
LE icon
864
Lands' End
LE
$392M
– –
-14,678
Closed -$207K
LFMD icon
865
LifeMD
LFMD
$188M
– –
-43,002
Closed -$292K
LFST icon
866
Lifestance Health
LFST
$4.24B
– –
-15,251
Closed -$83.9K
LFUS icon
867
Littelfuse
LFUS
$9.71B
– –
-905
Closed -$234K
LMAT icon
868
LeMaitre Vascular
LMAT
$2.34B
– –
-4,053
Closed -$355K
LNC icon
869
Lincoln National
LNC
$8.15B
– –
-8,079
Closed -$326K
LRCX icon
870
Lam Research
LRCX
$339B
– –
-2,116
Closed -$283K
LUNR icon
871
Intuitive Machines
LUNR
$2B
– –
-38,533
Closed -$405K
LYG icon
872
Lloyds Banking Group
LYG
$87.1B
– –
-10,340
Closed -$46.9K
LYTS icon
873
LSI Industries
LYTS
$866M
– –
-14,220
Closed -$336K
MA icon
874
Mastercard
MA
$496B
– –
-618
Closed -$352K
MAA icon
875
Mid-America Apartment Communities
MAA
$15.8B
– –
-1,769
Closed -$247K
33 34
35
36 37

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.